Timothy Joseph Souchek, PA
Physician Assistant · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Timothy Joseph Souchek’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$3,367
Medicare paid this office $3,367 for 34 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 30 | $2,961 | $96 |
Who their Medicare patients are
34 Original Medicare patients in 2024. Average age 76 · Women 59% · Health risk score 2.07. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 74% · Cancer 50%.
The office billed $10,159, Medicare allowed $4,175 and paid $3,367; for 36 services of 3 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 34 | 36 | 76 | 2.07 | $10,159 | $3,367 |
| 2023 | 266 | 511 | 75 | 1.84 | $140,379 | $42,792 |
| 2022 | 280 | 461 | 74 | 1.73 | $106,111 | $40,560 |
| 2021 | 367 | 694 | 74 | 1.83 | $156,119 | $59,633 |
| 2020 | 304 | 701 | 74 | 2.03 | $155,444 | $50,409 |
| 2019 | 361 | 580 | 73 | 1.94 | $139,046 | $41,925 |
| 2018 | 382 | 630 | 73 | 1.96 | $144,523 | $42,889 |
| 2017 | 416 | 609 | 73 | 2.07 | $116,507 | $38,496 |
| 2016 | 34 | 35 | 73 | 1.85 | $4,018 | $1,976 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 247 | $36,731 | $83 |
| Long return visit (40+ min) | 29 | $4,186 | $123 |
| Short return visit (20+ min) | 17 | $1,103 | $65 |
| Telephone medical discussion with physician, 5-10 minutes | 17 | $654 | $36 |
2022: 3 services
| Return visit (30+ min) | 235 | $33,048 | $88 |
| Long return visit (40+ min) | 34 | $5,001 | $128 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $437 | $31 |
2021: 5 services
| Return visit (30+ min) | 290 | $46,547 | $87 |
| Long return visit (40+ min) | 46 | $6,607 | $125 |
| New patient visit (45+ min) | 25 | $2,924 | $117 |
| Short return visit (20+ min) | 30 | $1,883 | $55 |
| Telephone medical discussion with physician, 5-10 minutes | 25 | $583 | $22 |
2020: 4 services
| Return visit (30+ min) | 245 | $37,233 | $73 |
| Long return visit (40+ min) | 77 | $8,615 | $97 |
| Short return visit (20+ min) | 47 | $3,090 | $53 |
| Telephone medical discussion with physician, 5-10 minutes | 31 | $768 | $24 |
2019: 4 services
| Return visit (30+ min) | 306 | $30,738 | $69 |
| Long return visit (40+ min) | 70 | $9,225 | $100 |
| Short return visit (20+ min) | 27 | $1,148 | $41 |
| New patient visit (45+ min) | 12 | $814 | $68 |
2018: 4 services
| Return visit (30+ min) | 331 | $32,923 | $67 |
| Long return visit (40+ min) | 39 | $4,153 | $97 |
| Short return visit (20+ min) | 53 | $2,762 | $42 |
| New patient visit (45+ min) | 28 | $2,540 | $91 |
2017: 3 services
| Return visit (30+ min) | 240 | $22,845 | $74 |
| Short return visit (20+ min) | 212 | $12,428 | $47 |
| New patient visit (45+ min) | 22 | $2,504 | $114 |
2016: 1 service
| Short return visit (20+ min) | 27 | $1,376 | $51 |
Medicaid work
$457 in 2023
Medicaid paid $457 for 15 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 15 | $457 |
| 2023 | 15 | 1 | 12 | $457 |
| 2022 | 15 | 1 | 15 | $345 |
| 2021 | 33 | 1 | 17 | $994 |
| 2020 | 48 | 1 | 15 | $1,193 |
| 2019 | 39 | 1 | 13 | $757 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 15 | $345 |
2021
| Return visit (30+ min) | 33 | $994 |
2020
| Return visit (30+ min) | 48 | $1,193 |
2019
| Return visit (30+ min) | 39 | $757 |
Drugs they prescribed that Part D paid
$4,406,717
Pharmacies billed $4,406,717 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 12% of their Part D prescriptions (193 of 1,634) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%. Long-acting opioids: 30% of their opioid prescriptions.
1,170 generic and fewer than 11 brand-name prescriptions · $4,406,717 in drug cost · 40 antibiotic prescriptions to 31 people · 35 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Imbruvica | 46 | $747,532 | $16,251 |
| Brukinsa | 54 | $552,201 | $10,226 |
| Jakafi | 25 | $437,189 | $17,488 |
| Tasigna | 21 | $423,491 | $20,166 |
| Revlimid | 23 | $343,477 | $14,934 |
See all 47 drugs
| Imbruvica | 46 | $747,532 | $16,251 |
| Brukinsa | 54 | $552,201 | $10,226 |
| Jakafi | 25 | $437,189 | $17,488 |
| Tasigna | 21 | $423,491 | $20,166 |
| Revlimid | 23 | $343,477 | $14,934 |
| Erleada | 20 | $236,301 | $11,815 |
| Xtandi | 12 | $163,002 | $13,583 |
| Doptelet | 12 | $154,947 | $12,912 |
| Lenalidomide | 11 | $95,882 | $8,717 |
| Promacta | 12 | $88,462 | $7,372 |
| Eliquis | 66 | $55,378 | $839 |
| Xarelto | 27 | $26,958 | $998 |
| Zenpep | 17 | $20,501 | $1,206 |
| Creon | 12 | $11,477 | $956 |
| Fentanyl | 29 | $2,894 | $100 |
| Hydroxyurea | 60 | $2,329 | $39 |
| Dabigatran Etexilate | 11 | $2,067 | $188 |
| Tamoxifen Citrate | 76 | $1,747 | $23 |
| Letrozole | 57 | $1,596 | $28 |
| Diphenoxylate-Atropine | 31 | $1,518 | $49 |
| Anastrozole | 68 | $1,453 | $21 |
| Gabapentin | 21 | $1,083 | $52 |
| Acyclovir | 66 | $1,082 | $16 |
| Morphine Sulfate Er | 25 | $976 | $39 |
| Azathioprine | 11 | $740 | $67 |
| Oxycodone | 28 | $669 | $24 |
| Ondansetron | 69 | $616 | $9 |
| Hydrocodone-Acetaminophen | 36 | $586 | $16 |
| Potassium Chloride | 40 | $535 | $13 |
| Oxycodone-Acetaminophen | 12 | $535 | $45 |
| Morphine Sulfate | 18 | $534 | $30 |
| Olanzapine | 40 | $533 | $13 |
| Levothyroxine | 39 | $441 | $11 |
| Escitalopram | 25 | $413 | $17 |
| Tramadol | 31 | $398 | $13 |
| Hydrocortisone | 20 | $286 | $14 |
| Dexamethasone | 14 | $284 | $20 |
| Pregabalin | 15 | $253 | $17 |
| Allopurinol | 16 | $225 | $14 |
| Pantoprazole | 15 | $214 | $14 |
| Ondansetron Odt | 21 | $209 | $10 |
| Trazodone | 21 | $203 | $10 |
| Lorazepam | 22 | $194 | $9 |
| Hydromorphone | 11 | $187 | $17 |
| Prednisone | 15 | $163 | $11 |
| Omeprazole | 14 | $87 | $6 |
| Alprazolam | 17 | $51 | $3 |
Year by year
| 2024 | 1,634 | 327 | 12% (193) | None | $4,406,717 |
| 2023 | 1,778 | 354 | 12% (214) | None | $5,074,233 |
| 2022 | 1,516 | 363 | 9% (143) | None | $4,455,679 |
| 2021 | 1,854 | 409 | 11% (205) | 24% | $3,377,006 |
| 2020 | 1,663 | 361 | 10% (173) | None | $2,388,806 |
| 2019 | 1,388 | 338 | 11% (156) | 24% | $2,376,911 |
| 2018 | 1,137 | 323 | 15% (169) | 25% | $1,664,387 |
| 2017 | 1,120 | 344 | 10% (109) | None | $1,449,061 |
| 2016 | 1,617 | 287 | 6% (94) | None | $144,556 |
| 2015 | 1,110 | 274 | 11% (122) | None | $68,801 |
| 2014 | 880 | 254 | 6% (56) | 16% | $129,339 |
| 2013 | 1,144 | 244 | 15% (175) | None | $274,985 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 49 drugs
| Imbruvica | 63 | $1,043,528 | $16,564 |
| Tagrisso | 22 | $606,251 | $27,557 |
| Brukinsa | 50 | $489,407 | $9,788 |
| Revlimid | 24 | $457,999 | $19,083 |
| Tasigna | 26 | $417,583 | $16,061 |
| Lenalidomide | 19 | $265,312 | $13,964 |
| Jakafi | 14 | $262,468 | $18,748 |
| Erleada | 12 | $202,018 | $16,835 |
| Calquence | 13 | $200,010 | $15,385 |
| Promacta | 15 | $101,873 | $6,792 |
| Xarelto | 44 | $41,675 | $947 |
| Abiraterone Acetate | 12 | $39,530 | $3,294 |
| Eliquis | 37 | $37,954 | $1,026 |
| Creon | 18 | $25,423 | $1,412 |
| Imatinib Mesylate | 18 | $5,866 | $326 |
| Tamoxifen Citrate | 105 | $4,227 | $40 |
| Dabigatran Etexilate | 11 | $3,050 | $277 |
| Hydroxyurea | 69 | $2,932 | $42 |
| Letrozole | 77 | $2,773 | $36 |
| Anastrozole | 62 | $1,824 | $29 |
| Hydrocodone-Acetaminophen | 67 | $1,384 | $21 |
| Morphine Sulfate Er | 43 | $1,160 | $27 |
| Acyclovir | 52 | $1,003 | $19 |
| Gabapentin | 36 | $994 | $28 |
| Hydromorphone | 55 | $908 | $17 |
| Ondansetron | 79 | $865 | $11 |
| Azathioprine | 12 | $856 | $71 |
| Pregabalin | 21 | $849 | $40 |
| Levothyroxine | 38 | $824 | $22 |
| Olanzapine | 26 | $651 | $25 |
| Potassium Chloride | 29 | $540 | $19 |
| Ondansetron Odt | 28 | $533 | $19 |
| Dexamethasone | 26 | $470 | $18 |
| Omeprazole | 21 | $456 | $22 |
| Prednisone | 44 | $451 | $10 |
| Lorazepam | 22 | $251 | $11 |
| Tamsulosin | 12 | $234 | $19 |
| Testosterone Cypionate | 11 | $212 | $19 |
| Trazodone | 22 | $211 | $10 |
| Furosemide | 13 | $190 | $15 |
| Oxycodone | 12 | $162 | $13 |
| Alprazolam | 18 | $158 | $9 |
| Levofloxacin | 15 | $153 | $10 |
| Tramadol | 14 | $147 | $11 |
| Amlodipine Besylate | 12 | $109 | $9 |
| Oxycodone-Acetaminophen | 12 | $105 | $9 |
| Azithromycin | 16 | $72 | $4 |
| Promethazine | 11 | $63 | $6 |
| Hydrochlorothiazide | 13 | $47 | $4 |
2022: 37 drugs
| Revlimid | 66 | $1,186,443 | $17,976 |
| Jakafi | 34 | $574,042 | $16,884 |
| Imbruvica | 36 | $557,608 | $15,489 |
| Brukinsa | 27 | $305,184 | $11,303 |
| Tagrisso | 17 | $279,666 | $16,451 |
| Tasigna | 16 | $233,268 | $14,579 |
| Promacta | 28 | $190,276 | $6,796 |
| Ibrance | 13 | $172,220 | $13,248 |
| Lynparza | 11 | $167,968 | $15,270 |
| Eliquis | 40 | $33,358 | $834 |
| Xarelto | 39 | $33,176 | $851 |
| Creon | 18 | $28,040 | $1,558 |
| Hydroxyurea | 81 | $3,356 | $41 |
| Tamoxifen Citrate | 71 | $2,602 | $37 |
| Letrozole | 88 | $2,583 | $29 |
| Anastrozole | 46 | $1,501 | $33 |
| Pregabalin | 22 | $1,291 | $59 |
| Hydrocodone-Acetaminophen | 53 | $1,044 | $20 |
| Ondansetron | 66 | $965 | $15 |
| Levothyroxine | 43 | $804 | $19 |
| Morphine Sulfate Er | 20 | $756 | $38 |
| Dexamethasone | 28 | $714 | $25 |
| Ondansetron Odt | 21 | $572 | $27 |
| Hydrocortisone | 17 | $550 | $32 |
| Prednisone | 36 | $536 | $15 |
| Hydromorphone | 23 | $525 | $23 |
| Acyclovir | 43 | $472 | $11 |
| Potassium Chloride | 18 | $376 | $21 |
| Trazodone | 26 | $336 | $13 |
| Gabapentin | 28 | $316 | $11 |
| Morphine Sulfate | 15 | $312 | $21 |
| Omeprazole | 23 | $247 | $11 |
| Tramadol | 11 | $207 | $19 |
| Escitalopram | 17 | $202 | $12 |
| Prochlorperazine Maleate | 16 | $133 | $8 |
| Alprazolam | 17 | $101 | $6 |
| Promethazine | 11 | $74 | $7 |
2021: 49 drugs
| Revlimid | 41 | $774,945 | $18,901 |
| Tagrisso | 28 | $451,570 | $16,127 |
| Imbruvica | 33 | $445,431 | $13,498 |
| Ibrance | 17 | $231,574 | $13,622 |
| Jakafi | 14 | $218,361 | $15,597 |
| Calquence | 16 | $212,614 | $13,288 |
| Tasigna | 20 | $150,117 | $7,506 |
| Promacta | 22 | $129,129 | $5,869 |
| Xarelto | 63 | $47,452 | $753 |
| Eliquis | 55 | $40,200 | $731 |
| Creon | 23 | $35,139 | $1,528 |
| Enoxaparin | 12 | $6,671 | $556 |
| Cyclosporine | 12 | $5,865 | $489 |
| Octreotide Acetate | 14 | $3,899 | $278 |
| Hydroxyurea | 88 | $3,585 | $41 |
| Tamoxifen Citrate | 52 | $2,101 | $40 |
| Letrozole | 68 | $1,836 | $27 |
| Hydrocodone-Acetaminophen | 75 | $1,280 | $17 |
| Anastrozole | 43 | $1,113 | $26 |
| Dexamethasone | 40 | $1,076 | $27 |
| Fentanyl | 14 | $1,073 | $77 |
| Morphine Sulfate Er | 31 | $1,022 | $33 |
| Pregabalin | 11 | $897 | $82 |
| Ondansetron | 77 | $858 | $11 |
| Diphenoxylate-Atropine | 27 | $817 | $30 |
| Omeprazole | 39 | $759 | $19 |
| Oxycodone-Acetaminophen | 12 | $753 | $63 |
| Hydromorphone | 34 | $733 | $22 |
| Potassium Chloride | 20 | $733 | $37 |
| Levothyroxine | 25 | $600 | $24 |
| Acyclovir | 51 | $577 | $11 |
| Prednisone | 74 | $486 | $7 |
| Oxycodone | 19 | $479 | $25 |
| Ondansetron Odt | 24 | $397 | $17 |
| Levofloxacin | 16 | $362 | $23 |
| Prochlorperazine Maleate | 29 | $357 | $12 |
| Gabapentin | 41 | $354 | $9 |
| Nystatin | 11 | $305 | $28 |
| Trazodone | 21 | $245 | $12 |
| Lorazepam | 26 | $228 | $9 |
| Escitalopram | 13 | $207 | $16 |
| Pantoprazole | 13 | $182 | $14 |
| Olanzapine | 12 | $168 | $14 |
| Zolpidem | 25 | $166 | $7 |
| Allopurinol | 14 | $156 | $11 |
| Furosemide | 16 | $126 | $8 |
| Quetiapine | 19 | $112 | $6 |
| Alprazolam | 21 | $82 | $4 |
| Tramadol | 16 | $76 | $5 |
2020: 43 drugs
| Imbruvica | 53 | $741,429 | $13,989 |
| Revlimid | 41 | $650,801 | $15,873 |
| Promacta | 30 | $240,790 | $8,026 |
| Ibrance | 15 | $187,535 | $12,502 |
| Thalomid | 13 | $102,634 | $7,895 |
| Xarelto | 33 | $22,161 | $672 |
| Eliquis | 25 | $18,272 | $731 |
| Hydroxyurea | 62 | $3,264 | $53 |
| Tamoxifen Citrate | 54 | $3,010 | $56 |
| Letrozole | 81 | $2,022 | $25 |
| Ondansetron | 112 | $1,923 | $17 |
| Valacyclovir | 12 | $1,328 | $111 |
| Hydrocodone-Acetaminophen | 58 | $962 | $17 |
| Morphine Sulfate Er | 27 | $936 | $35 |
| Dexamethasone | 31 | $889 | $29 |
| Azathioprine | 13 | $674 | $52 |
| Potassium Chloride | 19 | $626 | $33 |
| Diphenoxylate-Atropine | 22 | $619 | $28 |
| Acyclovir | 40 | $603 | $15 |
| Hydromorphone | 21 | $555 | $26 |
| Levothyroxine | 17 | $511 | $30 |
| Ondansetron Odt | 34 | $461 | $14 |
| Prednisone | 61 | $448 | $7 |
| Gabapentin | 42 | $443 | $11 |
| Omeprazole | 31 | $436 | $14 |
| Nystatin | 14 | $417 | $30 |
| Oxycodone | 24 | $355 | $15 |
| Anastrozole | 26 | $342 | $13 |
| Olanzapine | 32 | $325 | $10 |
| Escitalopram | 39 | $324 | $8 |
| Pantoprazole | 18 | $314 | $17 |
| Pregabalin | 11 | $312 | $28 |
| Hydrocortisone | 12 | $263 | $22 |
| Lorazepam | 35 | $199 | $6 |
| Prochlorperazine Maleate | 12 | $178 | $15 |
| Furosemide | 34 | $176 | $5 |
| Alprazolam | 21 | $88 | $4 |
| Hydrochlorothiazide | 15 | $87 | $6 |
| Carisoprodol | 13 | $78 | $6 |
| Zolpidem | 11 | $76 | $7 |
| Sulfamethoxazole-Trimethoprim | 16 | $52 | $3 |
| Tramadol | 17 | $47 | $3 |
| Methocarbamol | 13 | $39 | $3 |
2019: 35 drugs
| Imbruvica | 66 | $819,297 | $12,414 |
| Revlimid | 23 | $437,124 | $19,005 |
| Jakafi | 19 | $295,432 | $15,549 |
| Abiraterone Acetate | 12 | $75,607 | $6,301 |
| Eliquis | 40 | $21,505 | $538 |
| Creon | 18 | $20,783 | $1,155 |
| Xarelto | 24 | $18,833 | $785 |
| Tamoxifen Citrate | 114 | $5,186 | $45 |
| Hydroxyurea | 43 | $1,941 | $45 |
| Letrozole | 90 | $1,906 | $21 |
| Oxycodone-Acetaminophen | 14 | $768 | $55 |
| Valacyclovir | 13 | $737 | $57 |
| Morphine Sulfate Er | 24 | $677 | $28 |
| Ondansetron | 68 | $634 | $9 |
| Prednisone | 56 | $554 | $10 |
| Hydrocodone-Acetaminophen | 41 | $543 | $13 |
| Potassium Chloride | 15 | $479 | $32 |
| Oxycodone | 19 | $367 | $19 |
| Levothyroxine | 20 | $344 | $17 |
| Hydrocortisone | 12 | $344 | $29 |
| Omeprazole | 16 | $335 | $21 |
| Azathioprine | 11 | $318 | $29 |
| Anastrozole | 18 | $310 | $17 |
| Escitalopram | 28 | $299 | $11 |
| Nystatin | 12 | $237 | $20 |
| Acyclovir | 33 | $228 | $7 |
| Lorazepam | 27 | $175 | $6 |
| Gabapentin | 19 | $164 | $9 |
| Zolpidem | 18 | $146 | $8 |
| Finasteride | 14 | $140 | $10 |
| Olanzapine | 24 | $131 | $5 |
| Allopurinol | 21 | $129 | $6 |
| Tramadol | 26 | $81 | $3 |
| Furosemide | 21 | $79 | $4 |
| Alprazolam | 13 | $78 | $6 |
2018: 34 drugs
| Revlimid | 36 | $546,487 | $15,180 |
| Imbruvica | 36 | $425,164 | $11,810 |
| Zytiga | 11 | $114,565 | $10,415 |
| Xarelto | 41 | $22,847 | $557 |
| Creon | 15 | $17,292 | $1,153 |
| Eliquis | 35 | $14,939 | $427 |
| Hydrocodone-Acetaminophen | 54 | $1,587 | $29 |
| Oxycodone-Acetaminophen | 15 | $1,508 | $101 |
| Fentanyl | 14 | $1,378 | $98 |
| Tamoxifen Citrate | 35 | $1,198 | $34 |
| Hydroxyurea | 25 | $1,147 | $46 |
| Morphine Sulfate Er | 23 | $863 | $38 |
| Letrozole | 38 | $597 | $16 |
| Oxycodone | 23 | $433 | $19 |
| Diphenoxylate-Atropine | 13 | $407 | $31 |
| Anastrozole | 21 | $370 | $18 |
| Potassium Chloride | 15 | $366 | $24 |
| Ondansetron | 42 | $358 | $9 |
| Omeprazole | 35 | $325 | $9 |
| Levothyroxine | 30 | $311 | $10 |
| Gabapentin | 30 | $273 | $9 |
| Alprazolam | 16 | $267 | $17 |
| Ondansetron Odt | 15 | $264 | $18 |
| Dexamethasone | 16 | $264 | $16 |
| Prednisone | 39 | $242 | $6 |
| Hydromorphone | 12 | $236 | $20 |
| Lorazepam | 40 | $195 | $5 |
| Acyclovir | 26 | $175 | $7 |
| Pantoprazole | 18 | $174 | $10 |
| Allopurinol | 16 | $73 | $5 |
| Atenolol | 15 | $49 | $3 |
| Tramadol | 13 | $42 | $3 |
| Furosemide | 11 | $31 | $3 |
| Ranitidine | 11 | $22 | $2 |
2017: 31 drugs
| Revlimid | 59 | $714,904 | $12,117 |
| Jakafi | 17 | $209,239 | $12,308 |
| Imbruvica | 19 | $178,682 | $9,404 |
| Tamoxifen Citrate | 41 | $1,283 | $31 |
| Letrozole | 33 | $1,277 | $39 |
| Oxycodone-Acetaminophen | 12 | $1,066 | $89 |
| Fentanyl | 15 | $1,036 | $69 |
| Hydroxyurea | 24 | $827 | $34 |
| Ventolin Hfa | 12 | $641 | $53 |
| Hydrocodone-Acetaminophen | 30 | $598 | $20 |
| Morphine Sulfate Er | 11 | $545 | $50 |
| Ondansetron | 36 | $536 | $15 |
| Nystatin | 13 | $480 | $37 |
| Promethazine | 11 | $454 | $41 |
| Acyclovir | 19 | $405 | $21 |
| Oxycodone | 15 | $382 | $25 |
| Atorvastatin | 18 | $365 | $20 |
| Levothyroxine | 24 | $342 | $14 |
| Prednisone | 40 | $302 | $8 |
| Anastrozole | 24 | $289 | $12 |
| Pantoprazole | 14 | $260 | $19 |
| Dexamethasone | 24 | $244 | $10 |
| Allopurinol | 21 | $196 | $9 |
| Omeprazole | 15 | $170 | $11 |
| Lisinopril | 29 | $167 | $6 |
| Lorazepam | 29 | $159 | $5 |
| Losartan | 28 | $136 | $5 |
| Furosemide | 15 | $62 | $4 |
| Amlodipine Besylate | 12 | $57 | $5 |
| Citalopram Hbr | 12 | $57 | $5 |
| Atenolol | 13 | $25 | $2 |
2016: 44 drugs
| Advair Diskus | 17 | $6,746 | $397 |
| Lantus | 12 | $3,036 | $253 |
| Hydrocodone-Acetaminophen | 50 | $2,037 | $41 |
| Atorvastatin | 53 | $1,760 | $33 |
| Fentanyl | 11 | $1,113 | $101 |
| Levothyroxine | 51 | $938 | $18 |
| Allopurinol | 43 | $866 | $20 |
| Montelukast | 18 | $763 | $42 |
| Fluoxetine | 46 | $554 | $12 |
| Pantoprazole | 25 | $546 | $22 |
| Synthroid | 15 | $493 | $33 |
| Clonazepam | 11 | $476 | $43 |
| Zolpidem | 18 | $473 | $26 |
| Lisinopril | 74 | $445 | $6 |
| Simvastatin | 67 | $392 | $6 |
| Fluticasone Propionate | 27 | $353 | $13 |
| Amlodipine Besylate | 78 | $340 | $4 |
| Nitrofurantoin Mono-Macro | 16 | $330 | $21 |
| Metoprolol | 12 | $301 | $25 |
| Pravastatin | 15 | $300 | $20 |
| Losartan | 52 | $282 | $5 |
| Potassium Chloride | 17 | $269 | $16 |
| Azithromycin | 31 | $203 | $7 |
| Diclofenac | 14 | $200 | $14 |
| Furosemide | 36 | $184 | $5 |
| Hydrochlorothiazide | 51 | $171 | $3 |
| Losartan-Hydrochlorothiazide | 15 | $155 | $10 |
| Triamterene-Hydrochlorothiazid | 16 | $153 | $10 |
| Ciprofloxacin | 17 | $149 | $9 |
| Omeprazole | 16 | $137 | $9 |
| Sertraline | 13 | $135 | $10 |
| Cephalexin | 13 | $135 | $10 |
| Alprazolam | 11 | $130 | $12 |
| Ibuprofen | 16 | $120 | $8 |
| Citalopram Hbr | 18 | $97 | $5 |
| Escitalopram | 11 | $97 | $9 |
| Metoprolol | 16 | $84 | $5 |
| Tramadol | 16 | $84 | $5 |
| Paroxetine | 15 | $81 | $5 |
| Metformin Hcl Er | 16 | $77 | $5 |
| Metformin | 13 | $73 | $6 |
| Atenolol | 16 | $50 | $3 |
| Ropinirole | 12 | $48 | $4 |
| Lorazepam | 16 | $48 | $3 |
2015: 32 drugs
| Advair Diskus | 19 | $5,700 | $300 |
| Januvia | 12 | $4,088 | $341 |
| Hydrocodone-Acetaminophen | 81 | $3,198 | $39 |
| Oxycodone-Acetaminophen | 11 | $530 | $48 |
| Duloxetine | 12 | $418 | $35 |
| Zolpidem Tartrate Er | 11 | $375 | $34 |
| Atorvastatin | 17 | $354 | $21 |
| Levothyroxine | 20 | $305 | $15 |
| Allopurinol | 15 | $304 | $20 |
| Nitrofurantoin Mono-Macro | 16 | $295 | $18 |
| Lisinopril | 48 | $259 | $5 |
| Potassium Chloride | 18 | $252 | $14 |
| Amitriptyline | 18 | $239 | $13 |
| Fluoxetine | 38 | $220 | $6 |
| Azithromycin | 35 | $220 | $6 |
| Alprazolam | 21 | $178 | $8 |
| Warfarin | 21 | $176 | $8 |
| Zolpidem | 23 | $171 | $7 |
| Furosemide | 25 | $156 | $6 |
| Metformin | 14 | $144 | $10 |
| Ciprofloxacin | 21 | $137 | $7 |
| Simvastatin | 22 | $127 | $6 |
| Hydrochlorothiazide | 24 | $126 | $5 |
| Losartan | 22 | $125 | $6 |
| Lorazepam | 15 | $116 | $8 |
| Pantoprazole | 12 | $115 | $10 |
| Sertraline | 11 | $104 | $9 |
| Amlodipine Besylate | 29 | $103 | $4 |
| Donepezil | 15 | $69 | $5 |
| Ropinirole | 12 | $50 | $4 |
| Tramadol | 12 | $47 | $4 |
| Citalopram Hbr | 11 | $42 | $4 |
2014: 24 drugs
| Tarceva | 12 | $77,445 | $6,454 |
| Hydrocodone-Acetaminophen | 33 | $1,135 | $34 |
| Anastrozole | 60 | $1,021 | $17 |
| Letrozole | 29 | $773 | $27 |
| Tamoxifen Citrate | 34 | $611 | $18 |
| Gabapentin | 16 | $573 | $36 |
| Levothyroxine | 23 | $378 | $16 |
| Escitalopram | 15 | $334 | $22 |
| Nitrofurantoin Mono-Macro | 13 | $333 | $26 |
| Fluticasone Propionate | 20 | $290 | $15 |
| Tamsulosin | 12 | $278 | $23 |
| Azithromycin | 41 | $259 | $6 |
| Nitrofurantoin | 12 | $244 | $20 |
| Pantoprazole | 13 | $229 | $18 |
| Omeprazole | 20 | $195 | $10 |
| Metformin | 16 | $180 | $11 |
| Sertraline | 14 | $149 | $11 |
| Hydrochlorothiazide | 16 | $131 | $8 |
| Citalopram Hbr | 16 | $121 | $8 |
| Warfarin | 17 | $115 | $7 |
| Losartan | 13 | $113 | $9 |
| Ciprofloxacin | 23 | $110 | $5 |
| Lisinopril | 16 | $97 | $6 |
| Furosemide | 13 | $33 | $3 |
2013: 32 drugs
| Tarceva | 13 | $77,801 | $5,985 |
| Sancuso | 24 | $27,581 | $1,149 |
| Oxycontin | 30 | $9,194 | $306 |
| Ondansetron Odt | 17 | $3,348 | $197 |
| Letrozole | 92 | $3,289 | $36 |
| Escitalopram | 18 | $1,885 | $105 |
| Anastrozole | 78 | $1,853 | $24 |
| Hydroxyurea | 48 | $1,801 | $38 |
| Hydrocodone-Acetaminophen | 61 | $1,034 | $17 |
| Tamoxifen Citrate | 56 | $929 | $17 |
| Acyclovir | 13 | $737 | $57 |
| Oxycodone | 29 | $712 | $25 |
| Morphine Sulfate Er | 11 | $623 | $57 |
| Nystatin | 13 | $598 | $46 |
| Gabapentin | 18 | $504 | $28 |
| Omeprazole | 32 | $502 | $16 |
| Hydromorphone | 18 | $409 | $23 |
| Warfarin | 40 | $345 | $9 |
| Ondansetron | 19 | $291 | $15 |
| Diphenoxylate-Atropine | 16 | $217 | $14 |
| Lorazepam | 25 | $215 | $9 |
| Dexamethasone | 12 | $200 | $17 |
| Fluconazole | 23 | $171 | $7 |
| Azithromycin | 20 | $163 | $8 |
| Klor-Con 10 | 13 | $138 | $11 |
| Sertraline | 12 | $127 | $11 |
| Prochlorperazine Maleate | 12 | $103 | $9 |
| Zolpidem | 17 | $103 | $6 |
| Prednisone | 22 | $82 | $4 |
| Levofloxacin | 11 | $80 | $7 |
| Clonazepam | 16 | $76 | $5 |
| Furosemide | 12 | $43 | $4 |
Money from drug and device companies
$523 in 2025
| 2025 | 10 | 20 | None | $523 |
| 2024 | 48 | 246 | None | $4,429 |
| 2023 | 49 | 210 | None | $3,750 |
| 2022 | 35 | 189 | None | $2,325 |
| 2021 | 33 | 197 | None | $2,254 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Pluvicto | $119 | 4 payments
|
| BeOne Medicines USA | Brukinsa | $94 | 3 payments
|
| Daiichi Sankyo | Enhertu | $68 | 3 payments
|
| GlaxoSmithKline | Jemperli | $63 | 2 payments
|
| Pfizer | Elrexfio | $45 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Calquence | $43 | 2 payments
|
See all 20 published payments
| Daiichi Sankyo | Meals · 2025-11-25 | Enhertu | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-28 | Calquence | $30 |
| PharmaEssentia USA | Meals · 2025-10-27 | Besremi | $19 |
| BeOne Medicines USA | Meals · 2025-09-29 | Brukinsa | $29 |
| Novartis Pharmaceuticals | Meals · 2025-09-15 | Pluvicto | $23 |
| Pfizer | Meals · 2025-09-10 | Elrexfio | $22 |
| BeOne Medicines USA | Meals · 2025-09-08 | Brukinsa | $33 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-29 | Calquence | $14 |
| Novartis Pharmaceuticals | Meals · 2025-08-25 | Pluvicto | $31 |
| BeOne Medicines USA | Meals · 2025-06-16 | Brukinsa | $31 |
| Novartis Pharmaceuticals | Meals · 2025-05-07 | Pluvicto | $32 |
| Daiichi Sankyo | Meals · 2025-04-02 | Enhertu | $19 |
| Blueprint Medicines | Meals · 2025-04-02 | Ayvakit | $26 |
| Daiichi Sankyo | Meals · 2025-03-31 | Vanflyta | $20 |
| Rigel Pharmaceuticals | Meals · 2025-02-25 | Tavalisse | $28 |
| Pfizer | Meals · 2025-02-10 | Elrexfio | $23 |
| GlaxoSmithKline | Meals · 2025-02-05 | Ojjaara | $28 |
| Novartis Pharmaceuticals | Meals · 2025-01-31 | Pluvicto | $33 |
| GlaxoSmithKline | Meals · 2025-01-27 | Jemperli | $34 |
| Array Biopharma | Meals · 2025-01-13 | Xalkori | $19 |
See earlier years (2024, 2023, 2022, 2021)
2024: $4,429
| Janssen Biotech | Carvykti | $382 | 23 payments
|
| Daiichi Sankyo | Enhertu | $336 | 20 payments
|
| Novartis Pharmaceuticals | Pluvicto | $287 | 16 payments
|
| Abbvie | Venclexta | $257 | 16 payments
|
| Exelixis | Cabometyx | $244 | 8 payments
|
| Pfizer | Elrexfio | $228 | 16 payments
|
| Astellas Pharma US | Padcev | $201 | 7 payments
|
| Merck Sharp & Dohme | Keytruda | $193 | 10 payments
|
| PharmaEssentia USA | Besremi | $183 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Calquence | $183 | 10 payments
|
| Lilly USA | Jaypirca | $172 | 7 payments
|
| GlaxoSmithKline | Ojjaara | $160 | 10 payments
|
| Genzyme | Enjaymo | $138 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $138 | 22 payments
|
| Genentech USA | Venclexta | $105 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | Iclusig | $102 | 5 payments
|
| Eisai | Lenvima | $90 | 5 payments
|
| Celgene | Reblozyl | $82 | 4 payments
|
| Sobi | Doptelet | $68 | 3 payments
|
| Blueprint Medicines | Ayvakit | $66 | 3 payments
|
| Alnylam Pharmaceuticals | Givlaari | $57 | 3 payments
|
| Karyopharm Therapeutics | Xpovio | $53 | 2 payments
|
| Taiho Oncology | Lonsurf | $50 | 2 payments
|
| Apellis Pharmaceuticals | Empaveli | $50 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $47 | 2 payments
|
| Puma Biotechnology | None | $47 | 2 payments
|
| Array Biopharma | Xalkori | $40 | 3 payments
|
| Stemline Therapeutics | Orserdu | $39 | 1 payment
|
| Recordati Rare Diseases Inc. | Sylvant | $39 | 2 payments
|
| Incyte | Jakafi | $33 | 2 payments
|
| ADC Therapeutics America | None | $29 | 1 payment
|
| Pharmacosmos Therapeutics | Monoferric | $29 | 1 payment
|
| Ipsen Biopharmaceuticals | Onivyde | $24 | 1 payment
|
| Coherus Biosciences | Udenyca | $23 | 1 payment
|
| Servier Pharmaceuticals | Tibsovo | $22 | 1 payment
|
| Jazz Pharmaceuticals | Zepzelca | $22 | 1 payment
|
| Genmab U.S. | Epkinly | $22 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $21 | 1 payment
|
| Rigel Pharmaceuticals | Rezlidhia | $20 | 2 payments
|
| Deciphera Pharmaceuticals | Qinlock | $20 | 1 payment
|
| Aveo Pharmaceuticals | Fotivda | $19 | 1 payment
|
| Sun Pharmaceutical Industries | None | $17 | 1 payment
|
| Mirati Therapeutics | Krazati | $16 | 1 payment
|
| BeiGene USA | Brukinsa | $16 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $16 | 1 payment
|
| MorphoSys US | Monjuvi | $16 | 1 payment
|
| Agios Pharmaceuticals | Pyrukynd | $15 | 1 payment
|
| Gilead Sciences | None | $14 | 1 payment
|
2023: $3,750
| AstraZeneca Pharmaceuticals LP | Lynparza | $270 | 14 payments
|
| Janssen Biotech | Imbruvica | $262 | 17 payments
|
| Daiichi Sankyo | Enhertu | $261 | 16 payments
|
| Genentech USA | Venclexta | $202 | 11 payments
|
| Bayer Healthcare Pharmaceuticals | Nubeqa | $178 | 9 payments
|
| Astellas Pharma US | Padcev | $166 | 16 payments
|
| Novartis Pharmaceuticals | Kisqali | $164 | 12 payments
|
| Pfizer | Inlyta | $162 | 11 payments
|
| Merck Sharp & Dohme | Keytruda | $139 | 7 payments
|
| GlaxoSmithKline | Zejula | $134 | 6 payments
|
| Janssen Scientific Affairs | Tecvayli | $125 | 1 payment
|
| Exelixis | Cabometyx | $114 | 5 payments
|
| Seagen | Adcetris | $113 | 6 payments
|
| Blueprint Medicines | Ayvakit | $104 | 4 payments
|
| Amgen | Lumakras | $95 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $90 | 4 payments
|
| Mirati Therapeutics | Krazati | $75 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Alunbrig | $70 | 3 payments
|
| Eisai | Lenvima | $63 | 3 payments
|
| Pharmacyclics LLC An AbbVie | Epkinly | $63 | 2 payments
|
| Sobi | Doptelet | $63 | 3 payments
|
| Puma Biotechnology | Nerlynx | $59 | 3 payments
|
| PharmaEssentia USA | Besremi | $59 | 2 payments
|
| Lilly USA | Verzenio | $52 | 3 payments
|
| Celgene | Reblozyl | $45 | 2 payments
|
| Taiho Oncology | Lonsurf | $44 | 2 payments
|
| Jazz Pharmaceuticals | Zepzelca | $40 | 2 payments
|
| MorphoSys US | Monjuvi | $40 | 2 payments
|
| Array Biopharma | Xalkori | $38 | 3 payments
|
| ADC Therapeutics America | None | $34 | 1 payment
|
| Ipsen Biopharmaceuticals | Tazverik | $33 | 2 payments
|
| ImmunoGen | Elahere | $32 | 2 payments
|
| Incyte | Jakafi | $31 | 2 payments
|
| Genmab U.S. | Epkinly | $31 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $30 | 2 payments
|
| Regeneron Healthcare Solutions | Libtayo | $28 | 1 payment
|
| Karyopharm Therapeutics | Xpovio | $22 | 1 payment
|
| Gilead Sciences | None | $22 | 1 payment
|
| Genzyme | Cablivi | $22 | 1 payment
|
| Rigel Pharmaceuticals | Rezlidhia | $20 | 1 payment
|
| Abbvie | Venclexta | $19 | 1 payment
|
| Recordati Rare Diseases Inc. | Sylvant | $19 | 1 payment
|
| Apellis Pharmaceuticals | Empaveli | $19 | 1 payment
|
| AVEO Pharmaceuticals | Fotivda | $19 | 1 payment
|
| Coherus Biosciences | Udenyca | $19 | 1 payment
|
| Secura Bio | Copiktra | $17 | 1 payment
|
| Cumberland Pharmaceuticals | Sancuso | $16 | 1 payment
|
| Stemline Therapeutics | Orserdu | $15 | 1 payment
|
| Organon | Ontruzant | $14 | 1 payment
|
2022: $2,325
| AstraZeneca Pharmaceuticals LP | Calquence | $206 | 12 payments
|
| Daiichi Sankyo | Injectafer | $206 | 15 payments
|
| Novartis Pharmaceuticals | Kisqali | $182 | 11 payments
|
| Amgen | Kyprolis | $181 | 7 payments
|
| Seagen | Adcetris | $139 | 7 payments
|
| Astellas Pharma US | Xospata | $134 | 14 payments
|
| Janssen Biotech | Erleada | $95 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Iclusig | $94 | 4 payments
|
| Eisai | Lenvima | $89 | 5 payments
|
| Blueprint Medicines | Ayvakit | $82 | 4 payments
|
| Merck Sharp & Dohme | Keytruda | $81 | 4 payments
|
| Pharmacyclics LLC an AbbVie | Imbruvica | $67 | 3 payments
|
| Sobi | Doptelet | $64 | 3 payments
|
| AMAG Pharmaceuticals | Feraheme | $63 | 3 payments
|
| AVEO Pharmaceuticals | Fotivda | $62 | 3 payments
|
| Genzyme | Jevtana | $55 | 3 payments
|
| Abbvie | Creon | $48 | 3 payments
|
| Exelixis | Cabometyx | $46 | 2 payments
|
| Array Biopharma | Braftovi | $41 | 2 payments
|
| MorphoSys US | Monjuvi | $36 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $34 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $34 | 2 payments
|
| Pfizer | Xalkori | $33 | 2 payments
|
| GlaxoSmithKline | Zejula | $31 | 1 payment
|
| Jazz Pharmaceuticals | Zepzelca | $28 | 1 payment
|
| TOLMAR Pharmaceuticals | Eligard | $25 | 2 payments
|
| EMD Serono | None | $21 | 1 payment
|
| Ipsen Biopharmaceuticals | Somatuline Depot | $20 | 1 payment
|
| Genentech USA | Tecentriq | $20 | 1 payment
|
| PharmaEssentia USA | Besremi | $20 | 1 payment
|
| Deciphera Pharmaceuticals | Qinlock | $20 | 1 payment
|
| Incyte | Monjuvi | $19 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $19 | 1 payment
|
| CTI BioPharma | Vonjo | $19 | 1 payment
|
| Apellis Pharmaceuticals | Empaveli | $14 | 1 payment
|
2021: $2,254
| Astellas Pharma US | Xtandi | $250 | 22 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $223 | 8 payments
|
| Alexion Pharmaceuticals | Ultomiris | $201 | 1 payment
|
| Novartis Pharmaceuticals | Mekinist | $143 | 11 payments
|
| Eisai | Lenvima | $116 | 6 payments
|
| Amgen | Kyprolis | $110 | 5 payments
|
| Incyte | Monjuvi | $109 | 7 payments
|
| Rigel Pharmaceuticals | Tavalisse | $96 | 3 payments
|
| AbbVie | Venclexta | $95 | 4 payments
|
| Seagen | Tukysa | $87 | 5 payments
|
| Pfizer | Ibrance | $81 | 5 payments
|
| AMAG Pharmaceuticals | Feraheme | $69 | 3 payments
|
| Genzyme | Sarclisa | $64 | 3 payments
|
| Exelixis | Cabometyx | $58 | 3 payments
|
| MorphoSys US | Monjuvi | $54 | 3 payments
|
| Janssen Biotech | Darzalex | $52 | 3 payments
|
| BeiGene USA | Brukinsa | $44 | 3 payments
|
| Daiichi Sankyo | Enhertu | $42 | 2 payments
|
| Secura Bio | Farydak | $42 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $40 | 2 payments
|
| Genentech USA | Venclexta | $37 | 2 payments
|
| Puma Biotechnology | Nerlynx | $32 | 2 payments
|
| Kite Pharma | None | $27 | 1 payment
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $26 | 1 payment
|
| Lilly USA | Erbitux | $25 | 2 payments
|
| EMD Serono | None | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $19 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $19 | 1 payment
|
| Dova Pharmaceuticals | Doptelet | $17 | 1 payment
|
| Blueprint Medicines | Gavreto | $17 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $15 | 1 payment
|
| Epizyme | Tazverik | $14 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Stivarga | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1194709881
- Licence
- CA PA 13772
- Trained
- University of California, Davis School of Medicine, 1995
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2005-12-06
- NPI last updated
- 2025-12-23
- NPI record certified
- 2025-12-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 715 Tank Farm Rd, San Luis Obispo, CA, 93401